LEGISLATION

New York law stops mail-order pharmacy mandate

Independent pharmacies in New York can breathe a sigh of relief with the passage of the Anti-Mandatory Mail Order Bill, which allows consumers the choice of where to fill their prescriptions. » More

CONTINUING EDUCATION

MTM and collaborative practice

Successful collaborative relationships with physicians and other healthcare providers greatly enhance patient care. Knowing how to build those relationships is job 1. Earn up to 2 CPE credits. » Click here to login and take the exams.

MEDICATION SAFETY

CDC, partners launch child prescription safety campaign

The Centers for Disease Control and Prevention and several other organizations recently launched an education program about safe medication storage around children and what to do in the event of an emergency. » More

Resource Center: Oral Anticoagulation in Atrial Fibrillation

Atrial fibrillation afflicts more than 2.3 million persons in the United States and is expected to increase 2.5-fold by 2050. To find risk stratifying tools and articles on emerging oral anticoagulant therapies, click here.

Survey

President Obama’s executive order to take action on the public health crisis of prescription drug shortages includes directing FDA to broaden reporting of potential shortages, expedite regulatory reviews, and increase staffing resources for the FDA’s Drug Shortages Program. Do you agree with his executive order?

a) Yes, it will definitely make a difference to the prescription drug shortages.
b) Yes, but it will take more than the order to fix the prescription drug shortages.
c) No, Congress should be enacting legislation to fix the prescription drug shortages.
d) No, the order will do little to help the prescription drug shortages.

Respond here and see what your colleagues think too.

Want to see the results of our last survey about the implications of the possible Express Scripts/Medco merger? Click here.

CLINICAL NEWS

Strict glycemic control may not help kidney patients

Both tight glycemic control and poor glycemic control are associated with worse outcomes in diabetics with chronic kidney disease, according to a new report in the Archives of Internal Medicine. » More

FDA approves lower-dose topical oxybutynin gel 3% for overactive bladder

FDA has approved Antares' topical oxybutynin gel 3% product for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. » More

OTC PRODUCTS

OTC Product News

In this section we showcase products and product news that ran up against space limitations or fell outside the parameters of recently featured categories in the print edition. » More

Voices

•	DT Blog
•	JP at Large
•	View from the Zoo
•	Viewpoints
•	Regulatory & Legal

Meetings & Events

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.